Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy -Global Market Status & Trend Report 2016-2026 Top 20 Countries Data
Report Summary
Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy -Global Market Status & Trend Report 2016-2026 Top 20 Countries Data offers a comprehensive analysis on Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy 2016-2021, and development forecast 2022-2026
Main manufacturers/suppliers of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy worldwide and market share by regions, with company and product introduction, position in the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market
Market status and development trend of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by types and applications
Cost and profit status of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy , and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy industry.
The report segments the global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market as:
Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
Allogeneic CAR T-Cells
Autologous CAR T-Cells
Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market: Application Segment Analysis (Consumption Volume and Market Share 206-2026; Downstream Customers and Market Analysis)
Hospital
Diagnostic Center
Others
Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market: Manufacturers Segment Analysis (Company and Product introduction, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume, Revenue, Price and Gross Margin):
Pfizer
Novartis
Bristol Myers Squibb
Legend Biotech
Sorrento Therapeutics
CARSGEN Therapeutics?Ltd
Juno Therapeutics
Kite Pharma
Atara Biotherapeutics
Carina Biotech
Guangzhou Xiangxue Pharmaceutical
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy -Global Market Status & Trend Report 2016-2026 Top 20 Countries Data offers a comprehensive analysis on Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy 2016-2021, and development forecast 2022-2026
Main manufacturers/suppliers of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy worldwide and market share by regions, with company and product introduction, position in the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market
Market status and development trend of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by types and applications
Cost and profit status of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy , and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy industry.
The report segments the global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market as:
Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
Allogeneic CAR T-Cells
Autologous CAR T-Cells
Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market: Application Segment Analysis (Consumption Volume and Market Share 206-2026; Downstream Customers and Market Analysis)
Hospital
Diagnostic Center
Others
Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market: Manufacturers Segment Analysis (Company and Product introduction, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales Volume, Revenue, Price and Gross Margin):
Pfizer
Novartis
Bristol Myers Squibb
Legend Biotech
Sorrento Therapeutics
CARSGEN Therapeutics?Ltd
Juno Therapeutics
Kite Pharma
Atara Biotherapeutics
Carina Biotech
Guangzhou Xiangxue Pharmaceutical
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL IMMUNOTHERAPY
1.1 Definition of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy in This Report
1.2 Commercial Types of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
1.2.1 Allogeneic CAR T-Cells
1.2.2 Autologous CAR T-Cells
1.3 Downstream Application of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
1.3.1 Hospital
1.3.2 Diagnostic Center
1.3.3 Others
1.4 Development History of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
1.5 Market Status and Trend of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy 2016-2026
1.5.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status and Trend 2016-2026
1.5.2 Regional Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status and Trend 2016-2026
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy 2016-2021
2.2 Sales Market of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Regions
2.2.1 Sales Volume of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Regions
2.2.2 Sales Value of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Regions
2.3 Production Market of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Regions
2.4 Global Market Forecast of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy 2022-2026
2.4.1 Global Market Forecast of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy 2022-2026
2.4.2 Market Forecast of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Regions 2022-2026
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Types
3.2 Sales Value of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Types
3.3 Market Forecast of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Downstream Industry
4.2 Global Market Forecast of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Countries
5.1.1 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Countries (2016-2021)
5.1.2 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Countries (2016-2021)
5.1.3 United States Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
5.1.4 Canada Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
5.1.5 Mexico Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
5.2 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Manufacturers
5.3 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Type (2016-2021)
5.3.1 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Type (2016-2021)
5.3.2 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2021)
5.4 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Downstream Industry (2016-2021)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Countries
6.1.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Countries (2016-2021)
6.1.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Countries (2016-2021)
6.1.3 Germany Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
6.1.4 UK Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
6.1.5 France Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
6.1.6 Italy Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
6.1.7 Russia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
6.1.8 Spain Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
6.1.9 Benelux Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
6.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Manufacturers
6.3 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Type (2016-2021)
6.3.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Type (2016-2021)
6.3.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2021)
6.4 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Downstream Industry (2016-2021)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Countries
7.1.1 Asia Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Countries (2016-2021)
7.1.2 Asia Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Countries (2016-2021)
7.1.3 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
7.1.4 Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
7.1.5 India Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
7.1.6 Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
7.1.7 Australia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
7.2 Asia Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Manufacturers
7.3 Asia Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Type (2016-2021)
7.3.1 Asia Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Type (2016-2021)
7.3.2 Asia Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2021)
7.4 Asia Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Downstream Industry (2016-2021)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Countries
8.1.1 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Countries (2016-2021)
8.1.2 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Countries (2016-2021)
8.1.3 Brazil Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
8.1.4 Argentina Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
8.1.5 Colombia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
8.2 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Manufacturers
8.3 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Type (2016-2021)
8.3.1 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Type (2016-2021)
8.3.2 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2021)
8.4 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Downstream Industry (2016-2021)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Countries
9.1.1 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Countries (2016-2021)
9.1.2 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Countries (2016-2021)
9.1.3 Middle East Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
9.1.4 Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
9.2 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Manufacturers
9.3 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Type (2016-2021)
9.3.1 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Type (2016-2021)
9.3.2 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2021)
9.4 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Downstream Industry (2016-2021)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL IMMUNOTHERAPY
10.1 Global Economy Situation and Trend Overview
10.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Downstream Industry Situation and Trend Overview
CHAPTER 11 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL IMMUNOTHERAPY MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Major Manufacturers
11.2 Production Value of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Major Manufacturers
11.3 Basic Information of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Major Manufacturer
11.3.2 Employees and Revenue Level of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL IMMUNOTHERAPY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Pfizer
12.1.1 Company profile
12.1.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
12.1.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Pfizer
12.2 Novartis
12.2.1 Company profile
12.2.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
12.2.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Novartis
12.3 Bristol Myers Squibb
12.3.1 Company profile
12.3.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
12.3.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Bristol Myers Squibb
12.4 Legend Biotech
12.4.1 Company profile
12.4.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
12.4.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Legend Biotech
12.5 Sorrento Therapeutics
12.5.1 Company profile
12.5.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
12.5.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Sorrento Therapeutics
12.6 CARSGEN Therapeutics?Ltd
12.6.1 Company profile
12.6.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
12.6.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of CARSGEN Therapeutics?Ltd
12.7 Juno Therapeutics
12.7.1 Company profile
12.7.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
12.7.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Juno Therapeutics
12.8 Kite Pharma
12.8.1 Company profile
12.8.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
12.8.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Kite Pharma
12.9 Atara Biotherapeutics
12.9.1 Company profile
12.9.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
12.9.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Atara Biotherapeutics
12.10 Carina Biotech
12.10.1 Company profile
12.10.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
12.10.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Carina Biotech
12.11 Guangzhou Xiangxue Pharmaceutical
12.11.1 Company profile
12.11.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
12.11.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Guangzhou Xiangxue Pharmaceutical
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL IMMUNOTHERAPY
13.1 Industry Chain of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL IMMUNOTHERAPY
14.1 Cost Structure Analysis of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
14.2 Raw Materials Cost Analysis of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
14.3 Labor Cost Analysis of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
14.4 Manufacturing Expenses Analysis of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy in This Report
1.2 Commercial Types of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
1.2.1 Allogeneic CAR T-Cells
1.2.2 Autologous CAR T-Cells
1.3 Downstream Application of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
1.3.1 Hospital
1.3.2 Diagnostic Center
1.3.3 Others
1.4 Development History of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
1.5 Market Status and Trend of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy 2016-2026
1.5.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status and Trend 2016-2026
1.5.2 Regional Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status and Trend 2016-2026
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy 2016-2021
2.2 Sales Market of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Regions
2.2.1 Sales Volume of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Regions
2.2.2 Sales Value of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Regions
2.3 Production Market of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Regions
2.4 Global Market Forecast of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy 2022-2026
2.4.1 Global Market Forecast of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy 2022-2026
2.4.2 Market Forecast of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Regions 2022-2026
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Types
3.2 Sales Value of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Types
3.3 Market Forecast of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Downstream Industry
4.2 Global Market Forecast of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Countries
5.1.1 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Countries (2016-2021)
5.1.2 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Countries (2016-2021)
5.1.3 United States Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
5.1.4 Canada Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
5.1.5 Mexico Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
5.2 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Manufacturers
5.3 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Type (2016-2021)
5.3.1 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Type (2016-2021)
5.3.2 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2021)
5.4 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Downstream Industry (2016-2021)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Countries
6.1.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Countries (2016-2021)
6.1.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Countries (2016-2021)
6.1.3 Germany Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
6.1.4 UK Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
6.1.5 France Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
6.1.6 Italy Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
6.1.7 Russia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
6.1.8 Spain Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
6.1.9 Benelux Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
6.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Manufacturers
6.3 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Type (2016-2021)
6.3.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Type (2016-2021)
6.3.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2021)
6.4 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Downstream Industry (2016-2021)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Countries
7.1.1 Asia Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Countries (2016-2021)
7.1.2 Asia Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Countries (2016-2021)
7.1.3 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
7.1.4 Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
7.1.5 India Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
7.1.6 Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
7.1.7 Australia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
7.2 Asia Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Manufacturers
7.3 Asia Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Type (2016-2021)
7.3.1 Asia Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Type (2016-2021)
7.3.2 Asia Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2021)
7.4 Asia Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Downstream Industry (2016-2021)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Countries
8.1.1 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Countries (2016-2021)
8.1.2 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Countries (2016-2021)
8.1.3 Brazil Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
8.1.4 Argentina Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
8.1.5 Colombia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
8.2 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Manufacturers
8.3 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Type (2016-2021)
8.3.1 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Type (2016-2021)
8.3.2 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2021)
8.4 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Downstream Industry (2016-2021)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Countries
9.1.1 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Countries (2016-2021)
9.1.2 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Countries (2016-2021)
9.1.3 Middle East Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
9.1.4 Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status (2016-2021)
9.2 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Manufacturers
9.3 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Type (2016-2021)
9.3.1 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales by Type (2016-2021)
9.3.2 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Type (2016-2021)
9.4 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Status by Downstream Industry (2016-2021)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL IMMUNOTHERAPY
10.1 Global Economy Situation and Trend Overview
10.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Downstream Industry Situation and Trend Overview
CHAPTER 11 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL IMMUNOTHERAPY MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Major Manufacturers
11.2 Production Value of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Major Manufacturers
11.3 Basic Information of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Major Manufacturer
11.3.2 Employees and Revenue Level of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL IMMUNOTHERAPY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Pfizer
12.1.1 Company profile
12.1.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
12.1.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Pfizer
12.2 Novartis
12.2.1 Company profile
12.2.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
12.2.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Novartis
12.3 Bristol Myers Squibb
12.3.1 Company profile
12.3.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
12.3.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Bristol Myers Squibb
12.4 Legend Biotech
12.4.1 Company profile
12.4.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
12.4.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Legend Biotech
12.5 Sorrento Therapeutics
12.5.1 Company profile
12.5.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
12.5.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Sorrento Therapeutics
12.6 CARSGEN Therapeutics?Ltd
12.6.1 Company profile
12.6.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
12.6.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of CARSGEN Therapeutics?Ltd
12.7 Juno Therapeutics
12.7.1 Company profile
12.7.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
12.7.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Juno Therapeutics
12.8 Kite Pharma
12.8.1 Company profile
12.8.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
12.8.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Kite Pharma
12.9 Atara Biotherapeutics
12.9.1 Company profile
12.9.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
12.9.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Atara Biotherapeutics
12.10 Carina Biotech
12.10.1 Company profile
12.10.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
12.10.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Carina Biotech
12.11 Guangzhou Xiangxue Pharmaceutical
12.11.1 Company profile
12.11.2 Representative Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
12.11.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin of Guangzhou Xiangxue Pharmaceutical
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL IMMUNOTHERAPY
13.1 Industry Chain of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL IMMUNOTHERAPY
14.1 Cost Structure Analysis of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
14.2 Raw Materials Cost Analysis of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
14.3 Labor Cost Analysis of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
14.4 Manufacturing Expenses Analysis of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
